Investor Alert

Portage Biotech Inc.



After Hours

 --Quotes are delayed by 20 min

Jan 21, 2022, 4:51 p.m.





0.00 0.00%


Volume 70

Quotes are delayed by 20 min


Previous close

$ 9.35

$ 8.89


-0.46 -4.92%

Day low

Day high




52 week low

52 week high




Declan Doogan

Founder of Biohaven Pharmaceutical Holding Co. Ltd., Portage Pharma Ltd. and Juvenescence Ltd., Declan Doogan is an American entrepreneur and businessperson who has been at the helm of 9 different companies and presently occupies the position of Chairman at Celleron Therapeutics Ltd., Independent Chairman at Biohaven Pharmaceutical Holding Co. Ltd., Chairman of iOX Therapeutics Ltd., Chairman at Causeway Therapeutics Ltd., Chairman at Spinifex Pharmaceuticals Pty Ltd. and Chairman for Portage Pharma Ltd. He is also on the board of 7 other companies.

In his past career Dr. Doogan was Chief Executive Officer & Chief Medical Officer at Amarin Corp. Plc, Senior Vice President-Clinical R&D at Pfizer Europe International Ltd., Senior VP & Head-Worldwide Development at Pfizer Inc. Senior Vice President-Clinical R&D at Pfizer Japan, Inc. and Senior Vice President-Head-Worldwide Development at Pfizer (St. Louis) (both are subsidiaries of Pfizer Inc.), Chief Medical Officer & Executive Vice President at Prometheus Laboratories, Inc., Professor at Kitasato University, Professor at Harvard T.H. Chan School of Public Health and Professor at the University of Glasgow School of Medicine.

He received a doctorate from the University of Glasgow and a doctorate from the University of Kent.


Date Shares Transaction Value
06/05/2020 372,561   0
06/05/2020 37,256,068   0
01/02/2018 6,100,000   854,000
01/02/2018 245,000   0
03/23/2017 2,600,000   0

Officers and Executives

Dr. Gregory H. Bailey
Dr. Ian B. Walters
Chief Executive Officer & Director
Mr. Steve Innaimo
Vice President-Project Management & Operations
Mr. Allan Lee Shaw
Chief Financial Officer
Dr. Robert A. Kramer
Chief Scientific Officer
Mr. Kamlesh Shah
Non-Executive Director
Dr. Declan Doogan
Independent Director
Mr. Steven Michael Mintz
Independent Director
Trending Tickers
  • /zigman2/quotes/201786389/composite USA+0.11%
  • /zigman2/quotes/205971581/composite VIXM+1.50%
  • /zigman2/quotes/204412041/composite KMX+0.98%
  • /zigman2/quotes/205782082/composite IT-0.70%
  • /zigman2/quotes/200387963/composite LINK+1.77%
Powered by StockTwits
Link to MarketWatch's Slice.